These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 23928148)
21. Surfactant Assisted Rapid-Release Liposomal Strategies Enhance the Antitumor Efficiency of Bufalin Derivative and Reduce Cardiotoxicity. Gao L; Zhang L; He F; Chen J; Zhao M; Li S; Wu H; Liu Y; Zhang Y; Ping Q; Hu L; Qiao H Int J Nanomedicine; 2021; 16():3581-3598. PubMed ID: 34079251 [TBL] [Abstract][Full Text] [Related]
22. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions. Han M; Liu X; Guo Y; Wang Y; Wang X Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147 [TBL] [Abstract][Full Text] [Related]
23. Precipitation-lyophilization-homogenization (PLH) for preparation of clarithromycin nanocrystals: influencing factors on physicochemical properties and stability. Morakul B; Suksiriworapong J; Leanpolchareanchai J; Junyaprasert VB Int J Pharm; 2013 Nov; 457(1):187-96. PubMed ID: 24076396 [TBL] [Abstract][Full Text] [Related]
24. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546 [TBL] [Abstract][Full Text] [Related]
25. Preparation, characterization and pharmacokinetics of cyadox nanosuspension. Sattar A; Chen D; Jiang L; Pan Y; Tao Y; Huang L; Liu Z; Xie S; Yuan Z Sci Rep; 2017 May; 7(1):2289. PubMed ID: 28536446 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. Wang Y; Ma Y; Zheng Y; Song J; Yang X; Bi C; Zhang D; Zhang Q Int J Pharm; 2013 Jan; 441(1-2):728-35. PubMed ID: 23089583 [TBL] [Abstract][Full Text] [Related]
27. Correlation of pharmacokinetic features and tissue distribution with toxicity of Q39, a hypoxic cell cytotoxic agent. Zhu D; Lou J; Wu H; Luo P; Li L Pharmazie; 2010 Sep; 65(9):683-9. PubMed ID: 21038846 [TBL] [Abstract][Full Text] [Related]
28. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation. Geng T; Banerjee P; Lu Z; Zoghbi A; Li T; Wang B Eur J Pharm Sci; 2017 Nov; 109():200-208. PubMed ID: 28811130 [TBL] [Abstract][Full Text] [Related]
29. Paclitaxel nanosuspensions for targeted chemotherapy - nanosuspension preparation, characterization, and use. Lee SE; Bairstow SF; Werling JO; Chaubal MV; Lin L; Murphy MA; DiOrio JP; Gass J; Rabinow B; Wang X; Zhang Y; Yang Z; Hoffman RM Pharm Dev Technol; 2014 Jun; 19(4):438-53. PubMed ID: 23617261 [TBL] [Abstract][Full Text] [Related]
30. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Gao Y; Li Z; Sun M; Li H; Guo C; Cui J; Li A; Cao F; Xi Y; Lou H; Zhai G Drug Dev Ind Pharm; 2010 Oct; 36(10):1225-34. PubMed ID: 20545506 [TBL] [Abstract][Full Text] [Related]
31. Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement. Li X; Yuan H; Zhang C; Chen W; Cheng W; Chen X; Ye X J Pharm Pharmacol; 2016 Aug; 68(8):980-8. PubMed ID: 27283220 [TBL] [Abstract][Full Text] [Related]
32. Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation. Tian JL; Ke X; Chen Z; Wang CJ; Zhang Y; Zhong TC Pharmazie; 2011 May; 66(5):362-7. PubMed ID: 21699070 [TBL] [Abstract][Full Text] [Related]
33. In vitro-in vivo evaluation of nanosuspension release from subcutaneously implantable osmotic pumps. Hill A; Geissler S; Meyring M; Hecht S; Weigandt M; Mäder K Int J Pharm; 2013 Jul; 451(1-2):57-66. PubMed ID: 23628403 [TBL] [Abstract][Full Text] [Related]
34. Sustained delivery of a camptothecin prodrug - CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity. Dong D; Hsiao CH; Giovanella BC; Wang Y; Chow DS; Li Z Int J Nanomedicine; 2019; 14():3799-3817. PubMed ID: 31213802 [No Abstract] [Full Text] [Related]
35. Preparation, Characterization and In Vivo Assessment of Repaglinide Nanosuspension for Oral Bioavailability Improvement. Zawar LR; Bari SB Recent Pat Drug Deliv Formul; 2018; 12(3):162-169. PubMed ID: 30003863 [TBL] [Abstract][Full Text] [Related]
36. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085 [TBL] [Abstract][Full Text] [Related]
37. Formulation and Molecular Dynamics Simulations of a Fusidic Acid Nanosuspension for Simultaneously Enhancing Solubility and Antibacterial Activity. Omolo CA; Kalhapure RS; Agrawal N; Rambharose S; Mocktar C; Govender T Mol Pharm; 2018 Aug; 15(8):3512-3526. PubMed ID: 29953816 [TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo evaluation of riccardin D nanosuspensions with different particle size. Liu G; Zhang D; Jiao Y; Guo H; Zheng D; Jia L; Duan C; Liu Y; Tian X; Shen J; Li C; Zhang Q; Lou H Colloids Surf B Biointerfaces; 2013 Feb; 102():620-6. PubMed ID: 23107940 [TBL] [Abstract][Full Text] [Related]
39. Blood-pool multifunctional nanoparticles formed by temperature-induced phase transition for cancer-targeting therapy and molecular imaging. Oh KS; Lee S; Na JH; Kim JY; Kim DE; Kim K; Kwon IC; Yuk SH; Jeong SY Int J Pharm; 2012 Nov; 437(1-2):192-202. PubMed ID: 22944301 [TBL] [Abstract][Full Text] [Related]
40. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors. Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]